Regulatory4 Nov 2026, 04:01 pm
Triochem Products Files Deviation/Variation Statement for Q2 FY27
AI Summary
Triochem Products Ltd has filed its statement of deviation or variation in the utilization of funds raised for the quarter ended September 30, 2026. As there were no public issues, rights issues, or preferential issues during this period, the statement indicates that no deviation or variation has occurred. The company has confirmed that the category-wise variation is also not applicable. The filing adheres to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended by a circular dated December 24, 2019. The statement was signed by Director Ramu S. Deora.
Key Highlights
- Statement of deviation/variation in fund utilization filed for Q2 FY27.
- No public, rights, or preferential issues occurred during the quarter.
- Category-wise variation in fund use is not applicable.
- Filing complies with SEBI LODR Regulations 32(1).
Price Impact
More from TRIPR